Article Versions Notes

Antonelli R, Jiménez C, Riley M, Servidei T, Riccardi R, Soriano A, Roma J, Martínez-Saez E, Martini M, Ruggiero A, et al. CN133, a Novel Brain-Penetrating Histone Deacetylase Inhibitor, Hampers Tumor Growth in Patient-Derived Pediatric Posterior Fossa Ependymoma Models. Cancers. 2020; 12(7):1922. https://doi.org/10.3390/cancers12071922

Antonelli, Roberta, Carlos Jiménez, Misha Riley, Tiziana Servidei, Riccardo Riccardi, Aroa Soriano, Josep Roma, Elena Martínez-Saez, Maurizio Martini, Antonio Ruggiero, and et al. 2020. "CN133, a Novel Brain-Penetrating Histone Deacetylase Inhibitor, Hampers Tumor Growth in Patient-Derived Pediatric Posterior Fossa Ependymoma Models" Cancers 12, no. 7: 1922. https://doi.org/10.3390/cancers12071922

Antonelli, R., Jiménez, C., Riley, M., Servidei, T., Riccardi, R., Soriano, A., Roma, J., Martínez-Saez, E., Martini, M., Ruggiero, A., Moreno, L., Sánchez de Toledo, J., Gallego, S., Bové, J., Hooker, J. M., & Segura, M. F. (2020). CN133, a Novel Brain-Penetrating Histone Deacetylase Inhibitor, Hampers Tumor Growth in Patient-Derived Pediatric Posterior Fossa Ependymoma Models. Cancers, 12(7), 1922. https://doi.org/10.3390/cancers12071922